Creating the next generation of genomic medicines
Enceladus Bio is a biotechnology company creating the next generation of genomic medicines. The company focuses on genetic medicine research and development, leveraging novel approaches to treat diseases through genomic interventions. Backed by NEA, Enceladus Bio is headquartered in New York, NY.